Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Clinical trial NCT05103904 · TERMINATED

Trial details

NCT number: NCT05103904
Sponsor: Emory University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Hepatocellular Carcinoma Stage III Hepatocellular Carcinoma AJCC v8 Stage IIIA Hepatocellular Carcinoma AJCC v8 Stage IIIB Hepatocellular Carcinoma AJCC v8 Stage IV Hepatocellular Carcinoma AJCC v8 Stage IVA Hepatocellular Carcinoma AJCC v8 Stage IVB Hepatocellular Carcinoma AJCC v8 Unresectable Hepatocellular Carcinoma

Start date: 2022-04-19
Primary completion: 2025-05-09
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.